The functional implication of this upregulation is an increased NK cell activation, with a mechanism dependent on the receptor NKG2D, which leads to an enhanced degranulation and NK cell-mediated killing of MM target cells. The gene discussed is KLRK1; the disease is Miyoshi myopathy.